PROFIL ANEMIA DAN TROMBOSITOPENIA PADA PASIEN SIROSIS HEPATIS NON HEPATITIS

PROFILE OF ANEMIA AND THROMBOCYTOPENIA IN PATIENTS WITH NON-HEPATITIS LIVER CIRRHOSIS

  • Vahira Nissha Matovani Ray RSU Ferdinan Lumban Tobing, Sibolga, Indonesia
  • Lider Olmen RSU Ferdinan Lumban Tobing, Sibolga, Indonesia
  • Dairion Gatot RSU Ferdinan Lumban Tobing, Sibolga, Indonesia
Keywords: Anemia, Sirosis Hepatis, Hb, Trombosit

Abstract

Anemia is a common hematological complication in liver cirrhosis, caused by gastrointestinal bleeding, hypersplenism, and bone marrow dysfunction. This study aimed to analyze the relationship between hematological parameters and the severity of non-hepatitis liver cirrhosis. A cross-sectional observational study was conducted on 30 patients with non-hepatitis liver cirrhosis at Dr. Ferdinand Lumbantobing General Hospital, Sibolga, from December 2023 to August 2024. Laboratory parameters included hemoglobin, MCV, MCHC, and platelet count, analyzed using the Spearman correlation test (p<0.05). Among 30 patients, 21 (70%) were male and 9 (30%) female. Macrocytic anemia was predominant (53.3%), followed by microcytic (26.7%) and normocytic (20%). Most patients (50%) were in Child-Pugh B class, and thrombocytopenia occurred in 70% of cases. Significant correlations were found between hemoglobin, MCV, MCHC, and platelet count with cirrhosis severity (p=0.00). These findings indicate that anemia, particularly macrocytic type, is closely linked to chronic liver disease progression. Hematological parameters may serve as simple and valuable clinical indicators for assessing disease severity. A significant relationship exists between anemia and the severity of non-hepatitis liver cirrhosis.

 

Abstrak
Anemia merupakan komplikasi hematologis yang sering dijumpai pada pasien sirosis hepatis, disebabkan oleh perdarahan saluran cerna, hipersplenisme, serta gangguan fungsi sumsum tulang. Penelitian ini bertujuan menganalisis hubungan antara parameter hematologi dan derajat keparahan sirosis hepatis non-hepatitis. Penelitian observasional dengan desain potong lintang ini melibatkan 30 pasien sirosis hepatis non-hepatitis di RSU Dr. Ferdinand Lumbantobing, Sibolga, periode Desember 2023-Agustus 2024. Data laboratorium meliputi kadar hemoglobin, MCV, MCHC, dan jumlah trombosit. Analisis menggunakan uji korelasi Spearman dengan tingkat signifikansi p<0,05. Dari total 30 pasien, 21 (70%) berjenis kelamin laki-laki dan 9 (30%) perempuan. Jenis anemia yang dominan adalah makrositik (53,3%), diikuti mikrositik (26,7%) dan normositik (20%). Sebagian besar pasien (50%) berada pada kategori sirosis sedang (Child-Pugh B), dan 70% mengalami trombositopenia. Terdapat hubungan signifikan antara hemoglobin, MCV, MCHC, dan trombosit dengan derajat keparahan sirosis hepatis (p=0,00).b Hasil ini menunjukkan bahwa anemia, khususnya makrositik, sering berkaitan dengan progresivitas penyakit hati kronis. Parameter hematologi berpotensi menjadi indikator klinis sederhana dalam menilai keparahan sirosis. Terdapat hubungan bermakna antara anemia dan derajat keparahan sirosis hepatis non-hepatitis. Parameter hematologi dapat digunakan sebagai indikator progresivitas penyakit hati kronis.

References

Manrai M, Dawra S, Kapoor R, Srivastava S, Singh A. Anemia in cirrhosis: An underestimated entity. World J Clin Cases. 2022;10(3):777-789. doi:10.12998/wjcc.v10.i3.777

Abdulkafi A, Ammar A, Hadeer S, Abbas N, Abdulwahhab A. Evaluation of the Relationship between Anemia and Liver Disease. Int J Integr Med. 2024;2:151-158.

Miwa T, Hatano Y, Kochi T, et al. Spur cell anemia related to alcoholic liver cirrhosis managed without liver transplantation: a case report and literature review. Clin J Gastroenterol. 2020;13(5):882-890. doi:10.1007/s12328-020-01142-3

Sarma PR. Red Cell Indices. In: Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd ed. Butterworths; 1990.

Sigal SH, Sherman Z, Jesudian A. Clinical Implications of Thrombocytopenia for the Cirrhotic Patient. Hepat Med. 2020;Volume 12:49-60. doi:10.2147/HMER.S244596

Lingas EC. Hematological Abnormalities in Cirrhosis: A Narrative Review. Cureus. Published online May 19, 2023. doi:10.7759/cureus.39239

Tomar MSi, Melwani* V, Trivedi A. Hematological abnormalities in chronic liver disease and their association with severity and types of chronic liver disease. Panacea Journal of Medical Sciences. 2023;13(3):681-686. doi:10.18231/j.pjms.2023.125

Inkalagi V, katti Priyanka. Study to evaluate the haematological profile of patients with chronic liver disease. Journal of Clinical and Basic Research. Published online 2023. https://api.semanticscholar.org/CorpusID:272738087

Singh S. Association of liver cirrhosis severity with anemia: does it matter? Ann Gastroenterol. Published online 2020. doi:10.20524/aog.2020.0478

Anitha S, Kane-Potaka J, Botha R, et al. Millets Can Have a Major Impact on Improving Iron Status, Hemoglobin Level, and in Reducing Iron Deficiency Anemia–A Systematic Review and Meta-Analysis. Front Nutr. 2021;8. doi:10.3389/fnut.2021.725529

Algassim AA, Elghazaly AA, Alnahdi AS, et al. Prognostic significance of hemoglobin level and autoimmune hemolytic anemia in SARS-CoV-2 infection. Ann Hematol. 2021;100(1):37-43. doi:10.1007/s00277-020-04256-3

Sato K, Inoue S, Ishibashi Y, et al. Association between low mean corpuscular hemoglobin and prognosis in patients with exacerbation of chronic obstructive pulmonary disease. Respir Investig. 2021;59(4):498-504. doi:10.1016/j.resinv.2021.01.006

Ren H, Li H, Deng G, et al. Severe anemia is associated with increased short-term and long-term mortality in patients hospitalized with cirrhosis. Ann Hepatol. 2023;28(6):101147. doi:10.1016/j.aohep.2023.101147

Dehghani SM, Shahramian I, Salehi H, Kasraian L, Ataollahi M, Tahani M. Evaluating the Association between Anemia and the Severity of Liver Disease in Children with Cirrhosis: A Cross-Sectional Study from 2015 to 2020. Pediatr Gastroenterol Hepatol Nutr. 2024;27(5):286. doi:10.5223/pghn.2024.27.5.286

Rashidi-Alavijeh J, Nuruzade N, Frey A, et al. Implications of anaemia and response to anaemia treatment on outcomes in patients with cirrhosis. JHEP Reports. 2023;5(4):100688. doi:10.1016/j.jhepr.2023.100688

Kapzan LJ. Iron status and anemia in patients with liver cirrhosis: Prevalence and impact on clinical outcomes. Preprint posted online 2019.

Zhao TY, Cong QW, Liu F, Yao LY, Zhu Y. Nonlinear Relationship Between Macrocytic Anemia and Decompensated Hepatitis B Virus Associated Cirrhosis: A Population-Based Cross-Sectional Study. Front Pharmacol. 2021;12. doi:10.3389/fphar.2021.755625

Published
2026-01-01
How to Cite
Ray, V. N. M., Olmen, L., & Gatot, D. (2026). PROFIL ANEMIA DAN TROMBOSITOPENIA PADA PASIEN SIROSIS HEPATIS NON HEPATITIS: PROFILE OF ANEMIA AND THROMBOCYTOPENIA IN PATIENTS WITH NON-HEPATITIS LIVER CIRRHOSIS. Jurnal Kedokteran STM (Sains Dan Teknologi Medik), 9(1). https://doi.org/10.30743/stm.v9i1.1022
Section
Research Article